 This study is taking place at the National Institutes of Health NIH. All outpatients, ages 8-21, enrolled in a research study either at the Pediatric Clinic or the Primary Immune Deficiency Clinic at the NIH with a diagnosis of pediatric cancer, NF-1 or PIDs will be invited to participate in this study. 